Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bioreactor
Pharma
Boehringer Ingelheim divests biologics CDMO unit in China
Blood products developer Raas will pay up to around $3 million to secure a 100% stake in a Boehringer Ingelheim biologics CDMO unit in China.
Fraiser Kansteiner
Sep 24, 2026 11:38am
New biologics-focused CDMO Rezon Bio launches in Europe
Sep 29, 2025 1:37pm
Fujifilm Biotechnologies christens $3.2B antibody plant in NC
Sep 24, 2025 1:00pm
AGC telegraphs 278 layoffs amid plans to sell 2 Colorado sites
Sep 16, 2025 4:01pm
Fujifilm's CDMO taps Danish plant DNA in design of new NC facility
Jul 7, 2025 8:18am
Fujifilm plots another $1.2B expansion, hiring spree at NC site
Apr 11, 2024 2:49pm
